Publikationen, an denen er mitarbeitet María Isidoro García (7)

2022

  1. Ten Years of Experience Support Pharmacogenetic Testing to Guide Individualized Drug Therapy

    Pharmaceutics, Vol. 14, Núm. 1

2021

  1. Economic impact of the application of a precision medicine model (5SPM) on psychotic patients

    Pharmacogenomics and Personalized Medicine, Vol. 14, pp. 1015-1025

2020

  1. Application of a pharmacogenetics-based precision medicine model (5SPM) to psychotic patients that presented poor response to neuroleptic therapy

    Journal of Personalized Medicine, Vol. 10, Núm. 4, pp. 1-16

2016

  1. Pharmacogenetics to prevent maniac affective switching with treatment for bipolar disorder: CYP2D6

    Pharmacogenomics, Vol. 17, Núm. 12, pp. 1291-1293

  2. Role of Pharmacogenetics in Improving the Safety of Psychiatric Care by Predicting the Potential Risks of Mania in CYP2D6 Poor Metabolizers Diagnosed with Bipolar Disorder

    Medicine (United States), Vol. 95, Núm. 6

2011

  1. Erratum: Discovery of the nonfunctional CYP2D6*31 allele in Spanish, Puerto Rican, and US Hispanic populations (European Journal of Clinical Pharmacology DOI: 10.1007/s00228-010-0831-4)

    European Journal of Clinical Pharmacology

2010

  1. Discovery of the nonfunctional CYP2D6*31 allele in Spanish, Puerto Rican, and US Hispanic populations

    European Journal of Clinical Pharmacology, Vol. 66, Núm. 9, pp. 859-864